Cleared Traditional

K140860 - ImmersiveTouch3 and MicrovisTouch

K140860 is an FDA 510(k) clearance for ImmersiveTouch3 and MicrovisTouch, manufactured by Immersivetouch. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 257-day FDA review.

K140860 · Immersivetouch · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2014
Decision
257d
Days
Class 2
Risk

K140860 is an FDA 510(k) clearance for the ImmersiveTouch3 and MicrovisTouch. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Immersivetouch (Westmont, US). The FDA issued a Cleared decision on December 16, 2014 after a review of 257 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Immersivetouch devices

FDA 510(k) Submission Details - K140860

510(k) Number K140860 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2014
Decision Date December 16, 2014
Days to Decision 257 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
150d slower than avg
Panel avg: 107d · This submission: 257d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2154
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K140860.
McKesson Radiology Mammography Plus
K142850 · Mckesson Medical Imaging Company · Jan 2015
UniWeb 8.0
K142514 · Ebm Technologies Incorporated · Dec 2014
HEPATIQ
K142891 · Hepatiq, LLC · Dec 2014
EXA
K142919 · Viztek, LLC · Dec 2014
ArthroPlan Digital Templating Software
K142944 · Arthromeda, Inc. · Dec 2014
IPACS MEDICAL IMAGE MANAGEMENT SYSTEM
K140797 · Visbion Limited · Dec 2014